Cargando…

Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension

BACKGROUND: Growth differentiation factor-15 (GDF-15) may be a biomarker of disease, protective response and/or prognosis, in older people with hypertension. AIMS: To correlate baseline GDF-15 levels with physical and vascular health data in this population. METHODS: Baseline blood samples were anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Barma, Maryam, Khan, Faisel, Price, Rosemary J. G., Donnan, Peter T., Messow, C. Martina, Ford, Ian, McConnachie, Alex, Struthers, Allan D., McMurdo, Marion E. T., Witham, Miles D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589783/
https://www.ncbi.nlm.nih.gov/pubmed/27734214
http://dx.doi.org/10.1007/s40520-016-0636-0
_version_ 1783262404328554496
author Barma, Maryam
Khan, Faisel
Price, Rosemary J. G.
Donnan, Peter T.
Messow, C. Martina
Ford, Ian
McConnachie, Alex
Struthers, Allan D.
McMurdo, Marion E. T.
Witham, Miles D.
author_facet Barma, Maryam
Khan, Faisel
Price, Rosemary J. G.
Donnan, Peter T.
Messow, C. Martina
Ford, Ian
McConnachie, Alex
Struthers, Allan D.
McMurdo, Marion E. T.
Witham, Miles D.
author_sort Barma, Maryam
collection PubMed
description BACKGROUND: Growth differentiation factor-15 (GDF-15) may be a biomarker of disease, protective response and/or prognosis, in older people with hypertension. AIMS: To correlate baseline GDF-15 levels with physical and vascular health data in this population. METHODS: Baseline blood samples were analysed using a GDF-15 ELISA assay kit. Correlations with baseline and 12-month outcome data, including measures of physical and vascular function, were performed. RESULTS: A total of 147 individuals, mean age 76.8 ± 4.7 years, were included. 77 (52 %) were male. Baseline log(10)GDF-15 showed significant correlations with age (r = 0.37, p < 0.001), total cholesterol (r = −0.33, p < 0.001) and 6-min walking distance (r = −0.37, p < 0.001). Age remained significantly associated with log(10)GDF-15 in multivariable analysis (beta = −0.29, p = 0.001). Baseline log(10)GDF-15 was significantly associated with decline in 6-min walk distance over 12 months (beta = −0.27, p = 0.01) in multivariable models. No significant correlations were seen with changes in vascular function over 12 months. CONCLUSION: Baseline GDF-15 predicts declining physical, but not vascular, function in our population.
format Online
Article
Text
id pubmed-5589783
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-55897832017-09-22 Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension Barma, Maryam Khan, Faisel Price, Rosemary J. G. Donnan, Peter T. Messow, C. Martina Ford, Ian McConnachie, Alex Struthers, Allan D. McMurdo, Marion E. T. Witham, Miles D. Aging Clin Exp Res Short Communication BACKGROUND: Growth differentiation factor-15 (GDF-15) may be a biomarker of disease, protective response and/or prognosis, in older people with hypertension. AIMS: To correlate baseline GDF-15 levels with physical and vascular health data in this population. METHODS: Baseline blood samples were analysed using a GDF-15 ELISA assay kit. Correlations with baseline and 12-month outcome data, including measures of physical and vascular function, were performed. RESULTS: A total of 147 individuals, mean age 76.8 ± 4.7 years, were included. 77 (52 %) were male. Baseline log(10)GDF-15 showed significant correlations with age (r = 0.37, p < 0.001), total cholesterol (r = −0.33, p < 0.001) and 6-min walking distance (r = −0.37, p < 0.001). Age remained significantly associated with log(10)GDF-15 in multivariable analysis (beta = −0.29, p = 0.001). Baseline log(10)GDF-15 was significantly associated with decline in 6-min walk distance over 12 months (beta = −0.27, p = 0.01) in multivariable models. No significant correlations were seen with changes in vascular function over 12 months. CONCLUSION: Baseline GDF-15 predicts declining physical, but not vascular, function in our population. Springer International Publishing 2016-10-12 2017 /pmc/articles/PMC5589783/ /pubmed/27734214 http://dx.doi.org/10.1007/s40520-016-0636-0 Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Short Communication
Barma, Maryam
Khan, Faisel
Price, Rosemary J. G.
Donnan, Peter T.
Messow, C. Martina
Ford, Ian
McConnachie, Alex
Struthers, Allan D.
McMurdo, Marion E. T.
Witham, Miles D.
Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
title Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
title_full Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
title_fullStr Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
title_full_unstemmed Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
title_short Association between GDF-15 levels and changes in vascular and physical function in older patients with hypertension
title_sort association between gdf-15 levels and changes in vascular and physical function in older patients with hypertension
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5589783/
https://www.ncbi.nlm.nih.gov/pubmed/27734214
http://dx.doi.org/10.1007/s40520-016-0636-0
work_keys_str_mv AT barmamaryam associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension
AT khanfaisel associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension
AT pricerosemaryjg associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension
AT donnanpetert associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension
AT messowcmartina associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension
AT fordian associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension
AT mcconnachiealex associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension
AT struthersalland associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension
AT mcmurdomarionet associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension
AT withammilesd associationbetweengdf15levelsandchangesinvascularandphysicalfunctioninolderpatientswithhypertension